Adicet Bio, Inc. announced that it will receive $80,000,000 in funding on July 25, 2019. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,820 KRW | +4.51% | +1.46% | +21.66% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
13,520 KRW | -0.29% | -0.95% | 137M | ||
992 USD | +0.48% | +0.88% | 107B | ||
1.615 USD | -0.31% | +20.68% | 133M | ||
1st Jan change | Capi. | |
---|---|---|
+21.66% | 71.16M | |
+16.98% | 3.11B | |
+12.82% | 1.77B | |
+8.43% | 1.52B | |
-11.54% | 1.2B | |
+15.63% | 796M | |
+9.99% | 669M | |
+32.49% | 567M | |
-4.17% | 505M | |
+46.43% | 482M |
- Stock Market
- Equities
- A241520 Stock
- News DSC Investment Inc.
- Adicet Bio, Inc. announced that it expects to receive $80 million in funding